Cargando…
Early clinical experience with imatinib in COVID-19: Searching for a dual effect
[Figure: see text]
Autores principales: | Morales-Ortega, Alejandro, Rivas-Prado, Luis, Frutos-Pérez, Begoña, Jaenes-Barrios, Beatriz, Farfán-Sedano, Ana Isabel, García-Parra, Carlos Javier, Hernández-Muniesa, Belén, Duarte-Millán, Miguel Ángel, Madroñal-Cerezo, Elena, Ontañón-Nasarre, Ana, Ruiz-Giardín, José Manuel, Bermejo, Fernando, García-Gil, Mario, Gonzalo-Pascua, Sonia, San Martín-López, Juan Víctor, Bernal-Bello, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862035/ https://www.ncbi.nlm.nih.gov/pubmed/33549625 http://dx.doi.org/10.1016/j.jinf.2021.02.002 |
Ejemplares similares
-
Imatinib might constitute a treatment option for lung involvement in COVID-19
por: Bernal-Bello, David, et al.
Publicado: (2020) -
Imatinib for COVID-19: A case report
por: Morales-Ortega, Alejandro, et al.
Publicado: (2020) -
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022) -
Imatinib in COVID-19: hope and caution
por: Bernal-Bello, David, et al.
Publicado: (2021) -
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors
por: San Martín-López, Juan Víctor, et al.
Publicado: (2023)